Cargando…

Melanoma-restricted genes

Human metastatic cutaneous melanoma has gained a well deserved reputation for its immune responsiveness. The reason(s) remain(s) unknown. We attempted previously to characterize several variables that may affect the relationship between tumor and host immune cells but, taken one at the time, none yi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ena, Panelli, Monica C, Zavaglia, Katia, Mandruzzato, Susanna, Hu, Nan, Taylor, Phil R, Seliger, Barbara, Zanovello, Paola, Freedman, Ralph S, Marincola, Francesco M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC527872/ https://www.ncbi.nlm.nih.gov/pubmed/15488140 http://dx.doi.org/10.1186/1479-5876-2-34

Ejemplares similares

A gene expression signature associated with survival in metastatic melanoma
por: Mandruzzato, Susanna, et al.
Publicado: (2006)

Polarized monocyte response to cytokine stimulation
por: Nagorsen, Dirk, et al.
Publicado: (2005)

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration
por: Panelli, Monica C, et al.
Publicado: (2002)

Selection and validation of endogenous reference genes using a high throughput approach
por: Jin, Ping, et al.
Publicado: (2004)

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon
por: Wang, Ena, et al.
Publicado: (2012)

Different maturation cocktails provide dendritic cells with different chemoattractive properties
por: Massa, Chiara, et al.
Publicado: (2015)

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments
por: Aricò, Eleonora, et al.
Publicado: (2011)

A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings
por: Wang, Ena, et al.
Publicado: (2003)

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
por: Panelli, Monica C, et al.
Publicado: (2004)

Monoallelic expression in melanoma
por: Silcock, Lee, et al.
Publicado: (2019)

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms
por: Stroncek, David F, et al.
Publicado: (2005)

Gene expression profiling of cutaneous wound healing
por: Deonarine, Kavita, et al.
Publicado: (2007)

Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism
por: Leisz, Sandra, et al.
Publicado: (2015)

Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets
por: Jin, Ping, et al.
Publicado: (2006)

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
por: Al Hashmi, Muna, et al.
Publicado: (2020)

IRF5 gene polymorphisms in melanoma
por: Uccellini, Lorenzo, et al.
Publicado: (2012)

The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
por: Wang, Ena, et al.
Publicado: (2012)

GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8(+ )T cells
por: Selleri, Silvia, et al.
Publicado: (2008)

Human miRNome profiling in colorectal cancer and liver metastasis development
por: Perilli, Lisa, et al.
Publicado: (2014)

Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
por: Pizzini, Silvia, et al.
Publicado: (2013)

Editorial: Novel roles for tumor-associated neutrophils
por: Mandruzzato, Susanna, et al.
Publicado: (2022)

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014)

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection
por: Panelli, Monica C, et al.
Publicado: (2007)

Translational Medicine is developing in China: A new venue for collaboration
por: Wang, Xiangdong, et al.
Publicado: (2011)

Reflections upon human cancer immune responsiveness to T cell-based therapy
por: Wang, Ena, et al.
Publicado: (2012)

A genetic inference on cancer immune responsiveness
por: Wang, Ena, et al.
Publicado: (2012)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

NGS technology applied to melanoma cell lines
por: De Giorgi, Valeria, et al.
Publicado: (2013)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion
por: Ayache, Saleh, et al.
Publicado: (2006)

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy
por: Sommariva, Michele, et al.
Publicado: (2013)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011)

MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
por: Ren, Jiaqiang, et al.
Publicado: (2009)

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
por: Wang, Ena, et al.
Publicado: (2020)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
por: Freedman, Ralph S, et al.
Publicado: (2004)

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
por: Haymaker, Cara L, et al.
Publicado: (2015)

The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012)

Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v34e0l4hpsdseirl2ehcnd0937